Tilray introduces new CBN oil for sleep

Tilray introduces new CBN oil for sleep

The cannabis company is launching Aphria CBN Night oil to fight insomnia

Tilray Brands, recognized for being the most relevant company in the global marijuana industry, is now thinking about people who have trouble falling asleep. Cannabinol (CBN) is the component used by Tilray¬†Medical to create an oil capable of giving patients a pleasant night’s sleep. The 50mg bottle contains 30mg of CBN and 10mg of Tetrahydrocannabinol (THC) per mg.

Insomnia is often defined as a problem in the quality of sleep with difficulty in falling asleep but also in maintaining it during the night. CBN is a substance present in cannabis whose sedative and relaxing properties induce improved sleep. The cannabis company announced yesterday the arrival of its Aphria CBN Night oil, whose main objective is to help improve the duration and quality of sleep. In addition to its respective doses of CBN and THC, the pot is composed of a broad-spectrum cannabis distillate.

Tilray claims that this new oil is intended to be used in conjunction with a nighttime routine. Anyone interested in having a good night’s sleep can get the bottle through Tilray Medical’s website. The company’s strong operations in Canada, the US, Europe, Australia and Latin America have given the company enough motivation to continue launching innovative products that help the well-being of its extensive customer portfolio.

Tilray was one of the first in the industry to obtain approval to produce medical cannabis in Canada. As if that were not enough, it also has one of the first GMP-certified cannabis production facilities in Europe, including Portugal and later Germany.

“Tilray Medical is committed to providing patients in Canada and around the globe with safe, high-quality cannabinoid-based medicine,” Tilray Canada President Blair Mac Neil said. “We are pleased to add a dedicated night oil to the Aphria medical portfolio and broaden our offering of effective medical cannabis products to patients with a wider range of needs.”